Paywalls and patents are making it increasingly difficult to design new drugs, largely due to the lock up of data which is slowing the flow of information.
A not for profit organisation has called on the pharmaceutical and technology industries to support greater collaboration around blockchain initiatives
It’s no secret that President Trump wants to reign in the pharmaceutical industry, but his administration’s efforts to lower drug prices are seemingly met with silence.
Findings from a phase III clinical trial of about 300 women may introduce PARP inhibitors as a new type of treatment for breast cancer
Mapping every cell of the human body is a top priority for scientists funded by a $3 billion investment by Facebook founder and his wife